Back

Discussion - Furosemide Withdrawal in Stable Chronic Outpatients with Heart Failure: a Double-blind, Multicenter, Randomized Trial

26 May 2019 (09:06 - 09:09)
Organised by:
Congress Presentation Part of: Late breaking trial II - Chronic heart failure Chronic Heart Failure HFA Premium Access Heart Failure 2019

12 More presentations in this session

Presentation thumbnail
Pharmacy-based interdisciplinary intervention for patients with chronic heart failure: results of the PHARM-CHF randomized controlled trial
Professor M. Schulz (Leipzig, DE)
Slides Video
Presentation thumbnail
Discussion - PHARM-CHF
Video
Presentation thumbnail
Patiromer to Enable Spironolactone in Patients with Resistant Hypertension and Chronic Kidney Disease (AMBER): Results in the Prespecified Subgroup with Heart Failure
Professor P. Rossignol (Monaco, MC)
Slides Video
Presentation thumbnail
Discussion - AMBER.
Video
Presentation thumbnail
Furosemide Withdrawal in Stable Chronic Outpatients with Heart Failure: a Double-blind, Multicenter, Randomized Trial
Doctor A. Biolo (Porto Alegre, BR)
Slides Video

Access the full session

Session thumbnail
Late breaking trial II - Chronic heart failure

The Event

Event poster

Heart Failure 2019

26 May 2019 09:06 CET
You may be interested in
thumbnail
Congress Session
Bridging gaps in heart failure care: primary care trends, exercise, kidney function, and global health perspectives
thumbnail
Congress Session
Nursing and Allied Professions Investigator Award
thumbnail
Congress Session
Which device might help your HFpEF patient?

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources